Close

Protalix (PLX) Gets $25M Milestone from Pfizer in FDA Approval of ELELYSO as Treatment of Type 1 Gaucher

Go back to Protalix (PLX) Gets $25M Milestone from Pfizer in FDA Approval of ELELYSO as Treatment of Type 1 Gaucher